Immunization of mice with peptomers covalently coupled to aluminum oxide nanoparticles

被引:39
作者
Frey, A
Mantis, N
Kozlowski, PA
Quayle, AJ
Bajardi, A
Perdomo, JJ
Robey, FA
Neutra, MR
机构
[1] Childrens Hosp, GI Cell Biol Res Lab, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Fearing Res Lab, Boston, MA 02115 USA
[5] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA
关键词
adjuvant; antibodies; vaccine;
D O I
10.1016/S0264-410X(99)00163-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Subunit vaccines generally require adjuvants to elicit immune responses, but adjuvants may alter the conformation of critical epitopes and reduce vaccine efficacy. We therefore tested an immunization strategy in which antigen is covalently coupled to aluminum oxide nanoparticles using a method that favors preservation of the native conformation. The test antigen consisted of "peptomers" (head-to-tail-linked peptide homopolymers) derived from the 4th conserved region (C4) of HIV-1 gp120 which is believed to be in an alpha-helical conformation prior to binding to CD4, Immune responses in mice to peptomer-nanoparticle conjugates were compared to responses elicited by free C4 peptide and C4 peptomers, with and without the hydrophilic adjuvant muramyl dipeptide (MDP). Highest peptomer-specific serum antibody responses were induced by peptomer-particles without MDP. Serum antibodies induced by peptomer-particles also showed highest reactivity towards recombinant, glycosylated gp120 and HIV-1 infected T cells. The results suggest that this novel vaccine approach could be useful for induction of immune responses against conformation-sensitive viral antigens without the need for additional adjuvants. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3007 / 3019
页数:13
相关论文
共 47 条
[1]  
AHLERS JD, 1993, J IMMUNOL, V150, P5647
[2]   Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence [J].
Ahlers, JD ;
Takeshita, T ;
Pendleton, CD ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10856-10861
[3]   CONSTRUCTION OF PEPTIDES ENCOMPASSING MULTIDETERMINANT CLUSTERS OF HUMAN-IMMUNODEFICIENCY-VIRUS ENVELOPE TO INDUCE INVITRO T-CELL RESPONSES IN MICE AND HUMANS OF MULTIPLE MHC TYPES [J].
BERZOFSKY, JA ;
PENDLETON, CD ;
CLERICI, M ;
AHLERS, J ;
LUCEY, DR ;
PUTNEY, SD ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (03) :876-884
[4]   ENHANCEMENT OF PEPTIDE IMMUNOGENICITY BY LINEAR POLYMERIZATION [J].
BORRASCUESTA, F ;
FEDON, Y ;
PETITCAMURDAN, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (02) :199-202
[5]   NEUTRALIZATION OF HIV-1 BY SECRETORY IGA INDUCED BY ORAL IMMUNIZATION WITH A NEW MACROMOLECULAR MULTICOMPONENT PEPTIDE VACCINE CANDIDATE [J].
BUKAWA, H ;
SEKIGAWA, KI ;
HAMAJIMA, K ;
FUKUSHIMA, J ;
YAMADA, Y ;
KIYONO, H ;
OKUDA, K .
NATURE MEDICINE, 1995, 1 (07) :681-685
[6]   A vaccine for HIV type 1: The antibody perspective [J].
Burton, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (19) :10018-10023
[7]   HELPER T-CELL ANTIGENIC SITE IDENTIFICATION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME VIRUS GP120 ENVELOPE PROTEIN AND INDUCTION OF IMMUNITY IN MICE TO THE NATIVE PROTEIN USING A 16-RESIDUE SYNTHETIC PEPTIDE [J].
CEASE, KB ;
MARGALIT, H ;
CORNETTE, JL ;
PUTNEY, SD ;
ROBEY, WG ;
OUYANG, C ;
STREICHER, HZ ;
FISCHINGER, PJ ;
GALLO, RC ;
DELISI, C ;
BERZOFSKY, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (12) :4249-4253
[8]   INTERLEUKIN-2 PRODUCTION USED TO DETECT ANTIGENIC PEPTIDE RECOGNITION BY T-HELPER LYMPHOCYTES FROM ASYMPTOMATIC HIV-SEROPOSITIVE INDIVIDUALS [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
BERNSTEIN, DC ;
MANN, DL ;
SHEARER, GM ;
BERZOFSKY, JA .
NATURE, 1989, 339 (6223) :383-385
[9]   SINGLE AMINO-ACID CHANGES IN HIV ENVELOPE AFFECT VIRAL TROPISM AND RECEPTOR-BINDING [J].
CORDONNIER, A ;
MONTAGNIER, L ;
EMERMAN, M .
NATURE, 1989, 340 (6234) :571-574
[10]  
DELGIUDICE G, 1986, J IMMUNOL, V137, P2952